The U.S. Food and Drug Administration is talking when they should be listening
On May 9-10, 2017, the U.S. Food and Drug Administration (FDA) held a workshop titled “Training health care providers on pain management and safe use of opioid analgesics — exploring the path forward.” I attended the workshop in person to offer comments on behalf of chronic pain patients. A summary of my observations at the time was published by the now-defunct Pain News Network. The following extended extract is from …
The U.S. Food and Drug Administration is talking when they should be listening






![Clinicians are failing at value-based care because no one taught them the system [PODCAST]](https://kevinmd.com/wp-content/uploads/bd31ce43-6fb7-4665-a30e-ee0a6b592f4c-190x100.jpeg)












![I have cerebral palsy and I’m a doctor. Here’s what policy cuts mean for patients like me. [PODCAST]](https://kevinmd.com/wp-content/uploads/Gemini_Generated_Image_u26efdu26efdu26e-190x100.png)